Our study showed that bMF-ICC was associated with CEA ≥ 5 μg/L, microvascular invasion, lymph node metastasis, bile duct invasion, and high Ki-67 expression (all p < 0.05). The gene discussed is CEACAM5; the disease is intrahepatic cholangiocarcinoma.